ALDOB represents a potential prognostic biomarker for patients with clear cell renal cell carcinoma

BACKGROUND: Previous studies have shown that aldolase B (ALDOB) might play controversial roles in multiple types of cancer, which could act as a cancer-promoting factor or a cancer-inhibiting factor depending on the subtype of the cancer. However, the role of ALDOB in clear cell renal cell carcinoma...

Descripción completa

Detalles Bibliográficos
Autores principales: Shao, Yuan, Wu, Bo, Yang, Zhen, Liu, Zihao, Ma, Yuan, Huang, Hua, Liu, Yang, Wang, Zeyuan, Hu, Weijing, Wang, Yong, Niu, Yuanjie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10170270/
https://www.ncbi.nlm.nih.gov/pubmed/37181232
http://dx.doi.org/10.21037/tau-22-743

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10170270/
https://www.ncbi.nlm.nih.gov/pubmed/37181232
http://dx.doi.org/10.21037/tau-22-743

Ejemplares similares